RÉSUMÉ
Xanthogranulomatous cholecystitis [XGC] is an unusual focal or diffuse destructive inflammatory process of the gallbladder that may mimic a malignant neoplasm with associated complications. We present a rare case of Xanthogranulomatous cholecystitis with associated complications of liver abscess and enterobiliary fistula that was diagnosed radiologically and confirmed on histopathology.
Sujet(s)
Adulte , Cholécystite/diagnostic , Cholécystite/imagerie diagnostique , Granulome/diagnostic , Granulome/imagerie diagnostique , Humains , Mâle , Anatomopathologie , Xanthomatose/diagnostic , Xanthomatose/imagerie diagnostiqueSujet(s)
Ancylostomatoidea/effets des médicaments et des substances chimiques , Ancylostomatoidea/croissance et développement , Animaux , Anthelminthiques/usage thérapeutique , Femelle , Doigts , Humains , Larva migrans/diagnostic , Larva migrans/traitement médicamenteux , Adulte d'âge moyen , Peau/parasitologieRÉSUMÉ
Background & objectives: Association of Epstein-Barr virus (EBV) with Hodgkin lymphoma (HL) is particularly high in low-income countries, and resistance to apoptosis might play a role in pathogenesis and survival. Data from previous studies are not consistent, and none is available in children. Thus this study was undertaken on Indian children with classical Hodgkin lymphoma to assess the significance of bcl-2, bak and p53 expression, and apoptotic index in relation with EBV status and treatment outcome with chemotherapy alone. Methods: Children (age<15 yr) with classical HL (n=143) were included in the study. Bcl-2, bak, p53, Ki67 and latent membrane protein-1 (LMP1) were detected by immunohistochemistry in pre-treatment lymph node biopsies. Apoptotic index was assessed by TdT-dUTP nick-end labelling (TUNEL). Results: Bcl-2, bak, p53 were expressed above positivity threshold in 83.3, 94.0 and 7.1 per cent of the cases respectively. More than 10 per cent of apoptotic tumour cells were seen in 60.4 per cent of the cases. 131 (91.6%) cases were EBV associated. EBV-positive cases had a significantly lower mean bak expression (p=0.001) and a lower apoptotic index, without higher proliferation index. Advanced stage showed a borderline association with bcl-2 expression in >25 per cent of tumour cells and p53 negative tumours. In univariate analysis, p53 positive cases, which were significantly associated with B symptoms, had a poorer overall survival (P=0.03) while low proliferation index was associated with poorer failurefree survival. Neither EBV status nor any of the apoptotic parameters studied showed independent association with survival. Interpretation & conclusion: EBV detection in children with classical Hodgkin lymphoma was associated with significant lower bak expression and with lower spontaneous apoptosis of H-RS cells suggesting that EBV-LMP1 might downregulate bak pro-apoptotic protein. this needs to be substantiated further.
Sujet(s)
Adolescent , Apoptose , Enfant , Enfant d'âge préscolaire , Infections à virus Epstein-Barr/métabolisme , Infections à virus Epstein-Barr/anatomopathologie , Femelle , Maladie de Hodgkin/métabolisme , Maladie de Hodgkin/anatomopathologie , Humains , Inde , Mâle , Protéines proto-oncogènes c-bcl-2/métabolisme , Études rétrospectives , Protéine p53 suppresseur de tumeur/métabolisme , Protéine Bak/métabolismeRÉSUMÉ
Blastomycosis is a chronic systemic fungal infection characteristically affecting the skin and lungs. Involvement of the central nervous system (CNS) is unusual, with cases generally presenting with meningitis, and rarely as intracranial mass lesion and solitary or multiple abscesses. Only two cases of intracranial extra-axial blastomycosis have been reported from India, and we report the third case, which presented as meningioma in a 23-year old female.
Sujet(s)
Adulte , Amphotéricine B/usage thérapeutique , Antifongiques/usage thérapeutique , Blastomycose/diagnostic , Encéphale/microbiologie , Infections fongiques du système nerveux central/diagnostic , Craniotomie , Diagnostic différentiel , Femelle , Tête/imagerie diagnostique , Humains , Inde , Imagerie par résonance magnétique , Méningiome/diagnosticRÉSUMÉ
BACKGROUND: Comparative trials of ursodeoxycholic acid (UDCA), vitamin E and weight management programs among patients with nonalcoholic fatty liver disease (NAFLD) are lacking. AIM: To find an effective single agent or combination of agents for management of NAFLD. METHODS: In this retrospective study, consecutive patient with histologically confirmed NAFLD with raised ALT were included. The patients received either weight management (exercise and therapeutic lifestyle changes [TLC] diet with a target to reduce body weight 10% in 6 months) (group I) ; weight management + UDCA (300 mg BID) (group II); or weight management + UDCA + vitamin E (400 mg OD) (group III). Outcome measure was normalization of ALT. RESULTS: 42 patients (18, 12 and 12 in groups I, II and III, respectively) were included between 1996 and 2004. All patients in group III normalized their ALT levels, which was significantly higher than numbers in group I (8/18) and group II (5/12); (p=0.003). Post treatment ALT was significantly lower in group III (28.6 [9.3]) as compared to group I (59.3 [32.2]) and group II (49.0[31.8]); (p=0.01). Type of therapy received was the only factor predictive of ALT normalization. CONCLUSION: Combination regimen containing vitamin E appears to be effective in normalizing ALT among NAFLD patients.